{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:20:46Z","timestamp":1761862846625},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T00:00:00Z","timestamp":1243296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10689-009-9251-y","type":"journal-article","created":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T06:26:28Z","timestamp":1243232788000},"page":"383-390","source":"Crossref","is-referenced-by-count":9,"title":["TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset"],"prefix":"10.1007","volume":"8","author":[{"given":"Carla","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Isabel","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Baptista","sequence":"additional","affiliation":[]},{"given":"L\u00facia","family":"Roque","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Regateiro","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Cirnes","sequence":"additional","affiliation":[]},{"given":"Robert M. W.","family":"Hofstra","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]},{"given":"S\u00e9rgio","family":"Castedo","sequence":"additional","affiliation":[]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,5,26]]},"reference":[{"key":"9251_CR1","first-page":"1365","volume":"43","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43:1365\u20131373","journal-title":"J Natl Cancer Inst"},{"key":"9251_CR2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747\u2013752","journal-title":"Ann Intern Med"},{"key":"9251_CR3","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1001\/jama.1982.03320440040031","volume":"247","author":"FP Li","year":"1982","unstructured":"Li FP, Fraumeni JF Jr (1982) Prospective study of a family cancer syndrome. JAMA 247:2692\u20132694. doi: 10.1001\/jama.247.19.2692","journal-title":"JAMA"},{"key":"9251_CR4","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358\u20135362","journal-title":"Cancer Res"},{"key":"9251_CR5","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/bjc.1994.468","volume":"70","author":"JM Birch","year":"1994","unstructured":"Birch JM, Heighway J, Teare MD et al (1994) Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. Br J Cancer 70:1176\u20131181","journal-title":"Br J Cancer"},{"key":"9251_CR6","first-page":"101","volume":"25","author":"RA Eeles","year":"1995","unstructured":"Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25:101\u2013124","journal-title":"Cancer Surv"},{"key":"9251_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","volume":"38","author":"A Chompret","year":"2001","unstructured":"Chompret A, Abel A, Stoppa-Lyonnet D et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43\u201347. doi: 10.1136\/jmg.38.1.43","journal-title":"J Med Genet"},{"key":"9251_CR8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233\u20131238. doi: 10.1126\/science.1978757","journal-title":"Science"},{"key":"9251_CR9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava S, Zou ZQ, Pirollo K et al (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747\u2013749. doi: 10.1038\/348747a0","journal-title":"Nature"},{"key":"9251_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","volume":"19","author":"M Olivier","year":"2002","unstructured":"Olivier M, Eeles R, Hollstein M et al (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607\u2013614. doi: 10.1002\/humu.10081","journal-title":"Hum Mutat"},{"key":"9251_CR11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.onc.1206155","volume":"22","author":"G Bougeard","year":"2003","unstructured":"Bougeard G, Brugi\u00e8res L, Chompret A et al (2003) Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 22:840\u2013846. doi: 10.1038\/sj.onc.1206155","journal-title":"Oncogene"},{"key":"9251_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10185","volume":"21","author":"JM Varley","year":"2003","unstructured":"Varley JM (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313\u2013320. doi: 10.1002\/humu.10185","journal-title":"Hum Mutat"},{"key":"9251_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jmg.2008.057570","volume":"45","author":"G Bougeard","year":"2008","unstructured":"Bougeard G, Sesbo\u00fc\u00e9 R, Baert-Desurmont S et al (2008) Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 45:535\u2013538. doi: 10.1136\/jmg.2008.057570","journal-title":"J Med Genet"},{"key":"9251_CR14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/3.12.2247","volume":"3","author":"MI Guti\u00e9rrez","year":"1994","unstructured":"Guti\u00e9rrez MI, Bhatia KG, Barreiro C et al (1994) A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum Mol Genet 3:2247\u20132248. doi: 10.1093\/hmg\/3.12.2247","journal-title":"Hum Mol Genet"},{"key":"9251_CR15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/302575","volume":"65","author":"JM Varley","year":"1999","unstructured":"Varley JM, McGown G, Thorncroft M et al (1999) Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. Am J Hum Genet 65:995\u20131006. doi: 10.1086\/302575","journal-title":"Am J Hum Genet"},{"key":"9251_CR16","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1054\/bjoc.2000.1167","volume":"82","author":"A Chompret","year":"2000","unstructured":"Chompret A, Brugi\u00e8res L, Ronsin M et al (2000) P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 82:1932\u20131937. doi: 10.1054\/bjoc.2000.1167","journal-title":"Br J Cancer"},{"key":"9251_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cancergencyto.2004.02.017","volume":"154","author":"I Bendig","year":"2004","unstructured":"Bendig I, Mohr N, Kramer F et al (2004) Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Cancer Genet Cytogenet 154:22\u201326. doi: 10.1016\/j.cancergencyto.2004.02.017","journal-title":"Cancer Genet Cytogenet"},{"key":"9251_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1997.328","volume":"76","author":"JM Varley","year":"1997","unstructured":"Varley JM, Evans DG, Birch JM (1997) Li-Fraumeni syndrome\u2014a molecular and clinical review. Br J Cancer 76:1\u201314","journal-title":"Br J Cancer"},{"key":"9251_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","volume":"119","author":"GL Bond","year":"2004","unstructured":"Bond GL, Hu W, Bond EE et al (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119:591\u2013602. doi: 10.1016\/j.cell.2004.11.022","journal-title":"Cell"},{"key":"9251_CR20","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.1158\/1078-0432.CCR-05-1139","volume":"11","author":"K Sotamaa","year":"2005","unstructured":"Sotamaa K, Liyanarachchi S, Mecklin JP et al (2005) p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res 11:6840\u20136844. doi: 10.1158\/1078-0432.CCR-05-1139","journal-title":"Clin Cancer Res"},{"key":"9251_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jnci\/djj054","volume":"98","author":"C Menin","year":"2006","unstructured":"Menin C, Scaini MC, De Salvo GL et al (2006) Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst 98:285\u2013288","journal-title":"J Natl Cancer Inst"},{"key":"9251_CR22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jmg.2005.037952","volume":"43","author":"G Bougeard","year":"2006","unstructured":"Bougeard G, Baert-Desurmont S, Tournier I et al (2006) Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J Med Genet 43:531\u2013533. doi: 10.1136\/jmg.2005.037952","journal-title":"J Med Genet"},{"key":"9251_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","volume":"33","author":"P Dumont","year":"2003","unstructured":"Dumont P, Leu JI, Della Pietra ACIII et al (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357\u2013365. doi: 10.1038\/ng1093","journal-title":"Nat Genet"},{"key":"9251_CR24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/0008-5472.CAN-06-3682","volume":"67","author":"U Tabori","year":"2007","unstructured":"Tabori U, Nanda S, Druker H et al (2007) Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res 67:1415\u20131418. doi: 10.1158\/0008-5472.CAN-06-3682","journal-title":"Cancer Res"},{"key":"9251_CR25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/cncr.22834","volume":"110","author":"M Trkova","year":"2007","unstructured":"Trkova M, Prochazkova K, Krutilkova V et al (2007) Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Cancer 110:694\u2013702. doi: 10.1002\/cncr.22834","journal-title":"Cancer"},{"key":"9251_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1520-6823(1999)7:1<13::AID-ROI2>3.0.CO;2-7","volume":"7","author":"PA Kruk","year":"1999","unstructured":"Kruk PA, Bohr VA (1999) Telomeric length in individuals and cell lines with altered p53 status. Radiat Oncol Investig 7:13\u201321. doi: 10.1002\/(SICI)1520-6823(1999)7:1<13::AID-ROI2>3.0.CO;2-7","journal-title":"Radiat Oncol Investig"},{"key":"9251_CR27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.dnarep.2005.05.010","volume":"4","author":"S Bekaert","year":"2005","unstructured":"Bekaert S, Derradji H, De Meyer T et al (2005) Telomere shortening is associated with malformation in p53-deficient mice after irradiation during specific stages of development. DNA Repair (Amst) 4:1028\u20131037. doi: 10.1016\/j.dnarep.2005.05.010","journal-title":"DNA Repair (Amst)"},{"key":"9251_CR28","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47. doi: 10.1093\/nar\/30.10.e47","journal-title":"Nucleic Acids Res"},{"key":"9251_CR29","unstructured":"IARC (2008) TP53 germline mutation database. http:\/\/www-p53.iarc.fr\/Germline.html . Accessed on 21 Nov 2008"},{"key":"9251_CR30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pbc.20603","volume":"47","author":"L Roque","year":"2006","unstructured":"Roque L, Lacerda A, Rodrigues R et al (2006) CGH evaluation of two de novo synchronous tumors in a child with a germline p53 mutation. Pediatr Blood Cancer 47:949\u2013954. doi: 10.1002\/pbc.20603","journal-title":"Pediatr Blood Cancer"},{"key":"9251_CR31","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","volume":"86","author":"AC Latronico","year":"2001","unstructured":"Latronico AC, Pinto EM, Domenice S et al (2001) An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 86:4970\u20134973. doi: 10.1210\/jc.86.10.4970","journal-title":"J Clin Endocrinol Metab"},{"key":"9251_CR32","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","volume":"98","author":"RC Ribeiro","year":"2001","unstructured":"Ribeiro RC, Sandrini F, Figueiredo B et al (2001) An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98:9330\u20139335. doi: 10.1073\/pnas.161479898","journal-title":"Proc Natl Acad Sci USA"},{"key":"9251_CR33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0004-27302004000500009","volume":"48","author":"EM Pinto","year":"2004","unstructured":"Pinto EM, Billerbeck AE, Villares MC et al (2004) Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq Bras Endocrinol Metabol 48:647\u2013650. doi: 10.1590\/S0004-27302004000500009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"9251_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.2004.030551","volume":"43","author":"BC Figueiredo","year":"2006","unstructured":"Figueiredo BC, Sandrini R, Zambetti GP et al (2006) Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet 43:91\u201396. doi: 10.1136\/jmg.2004.030551","journal-title":"J Med Genet"},{"key":"9251_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2007.10.044","volume":"261","author":"EI Palmero","year":"2008","unstructured":"Palmero EI, Sch\u00fcler-Faccini L, Caleffi M et al (2008) Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett 261:21\u201325. doi: 10.1016\/j.canlet.2007.10.044","journal-title":"Cancer Lett"},{"key":"9251_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10689-005-4789-9","volume":"5","author":"MW Ruijs","year":"2006","unstructured":"Ruijs MW, Verhoef S, Wigbout G et al (2006) Late-onset common cancers in a kindred with an Arg213Gln TP53 germline mutation. Fam Cancer 5:169\u2013174. doi: 10.1007\/s10689-005-4789-9","journal-title":"Fam Cancer"},{"key":"9251_CR37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ejca.2004.04.027","volume":"40","author":"C Oliveira","year":"2004","unstructured":"Oliveira C, Ferreira P, Nabais S et al (2004) E-cadherin (CDH1) and p53 rather than SMAD4 and caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 40:1897\u20131903. doi: 10.1016\/j.ejca.2004.04.027","journal-title":"Eur J Cancer"},{"key":"9251_CR38","first-page":"1231","volume":"9","author":"Y Horio","year":"1994","unstructured":"Horio Y, Suzuki H, Ueda R et al (1994) Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9:1231\u20131235","journal-title":"Oncogene"},{"key":"9251_CR39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/jmg.32.12.942","volume":"32","author":"JM Varley","year":"1995","unstructured":"Varley JM, McGown G, Thorncroft M et al (1995) An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet 32:942\u2013945. doi: 10.1136\/jmg.32.12.942","journal-title":"J Med Genet"},{"key":"9251_CR40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0959-8049(96)00492-3","volume":"33","author":"RJ Black","year":"1997","unstructured":"Black RJ, Bray F, Ferlay J et al (1997) Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33:1075\u20131107. doi: 10.1016\/S0959-8049(96)00492-3","journal-title":"Eur J Cancer"},{"key":"9251_CR41","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1136\/jmg.2003.015594","volume":"41","author":"G Keller","year":"2004","unstructured":"Keller G, Vogelsang H, Becker I et al (2004) Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 41:e89. doi: 10.1136\/jmg.2003.015594","journal-title":"J Med Genet"},{"key":"9251_CR42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10038-004-0193-9","volume":"49","author":"IJ Kim","year":"2004","unstructured":"Kim IJ, Kang HC, Shin Y et al (2004) A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J Hum Genet 49:591\u2013595. doi: 10.1007\/s10038-004-0193-9","journal-title":"J Hum Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9251-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-009-9251-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9251-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:45:59Z","timestamp":1559252759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-009-9251-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,26]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9251"],"URL":"https:\/\/doi.org\/10.1007\/s10689-009-9251-y","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,26]]}}}